- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01270360
Validation of an Alternative Biological Test to Increase the Detection Sensitivity of a Colon Tumour (VATNIMAD)
Validation of a Non Invasive methylateDNA Test for te Diagnosis of Colorectal Tumour in Asymptomatic Individuals
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This study search to validate a test by taking advantage of the biotechnical expertise from renowned academic research teams and mass screening organisation.
In order to reduce the cost of the present study the investigators will select in this preliminary study only those individuals who have a FOBT. However, we'll measure the blood level by using a I-FOBT test to quantify Haemoglobin concentration in stools. Furthermore, we'll use stool DNA to characterize microbiota according to the colonoscopy findings. In addition, the investigators believe it is important to include in the project, the creation of biological blood and urine collections from individuals having undergone both faecal tests and a reference colonoscopy. In the future, these collections will be made available to the national or international scientific community (after consent by the principal investigators) to validate any other molecular and/or protein marker including proteomic analysis by using MSS. The investigators will perform methylated DNA test in either stools or blood and will compare results to those of I-FOBT and colonoscopy.
A simplified molecular test based on a combination of the search for methylation anomalies (one PCR and/or dedicated microarray) a limited number of gene targets involved in colorectal carcinogenesis is available. The investigators will collect stools, urine, and blood in a period of 15 to 2 days prior to colonoscopy. The colonoscopy is performed in 50-74 years old asymptomatic individuals who have presented with a positive FOBT test under mass screening organisation. A final point will be performed 5 years after entry in the trial for all 1000 individuals in order to check occurrence (alternative absence) of any disease during this period and the type of the disease for those individuals who will be shown with normal colonoscopy and to verify evolution of those who will presented with a colon or rectal tumor. Likelihood value of marker in diseases occurring during the survey period will be calculated and prognostic values estimated in those with colon or rectal cancer.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
-
Creteil, Frankrike, 94010
- Henri Mondor Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
Every person (actually limited to the average risk of colorectal cancer in national French program):
- having been invited to participate in the organised screening for a colorectal tumour during the study period and having a result positive of the FOBTt
- having given his consent to participate in the study. Patients will be given an information notice at the start of the campaign informing them that participation in this part of the study is optional, to prevent uselessly encumbering the screening campaign operation. Written consent will be obtained before the colonoscopy by the GE for this part of the study
- going to a laboratory to hand over samples of stools, urine and blood prior to the colonoscopy
- being affiliated to social security
Exclusion Criteria:
- Those refusing the colonoscopy
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
---|---|
asymptomatic subjects with positive FOBT
individuals having undergone a positive faecal occult blood test (FOBT) and a reference colonoscopy
|
Detection of human colon or rectal tumours by using a simplified molecular test based on either a combination of methylated DNA or protein marker(s) alone or considered together in biological fluids like blood, urine and stools
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
To determine the performances (sensitivity, specificity and likelihood ratios) of a panel of blood and/or faecal molecular DNA markers
Tidsram: 3 years
|
To determine the performances (sensitivity, specificity and likelihood ratios) of a panel of blood and/or faecal molecular DNA markers
|
3 years
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
To estimate the cost and cost-effectiveness of adding DNA molecular tests to FOBT positive patients prior to colonoscopy
Tidsram: 3 years
|
To estimate the cost and cost-effectiveness of adding DNA molecular tests to FOBT positive patients prior to colonoscopy
|
3 years
|
To determine the performances (sensitivity, specificity and likelihood ratios) of a panel of blood and/or faecal molecular protein markers
Tidsram: 3 years
|
To determine the performances (sensitivity, specificity and likelihood ratios) of a panel of blood and/or faecal molecular protein markers
|
3 years
|
To create biological collections for screening purposes (asymptomatic subjects)
Tidsram: 3 years
|
To create biological collections for screening purposes (asymptomatic subjects)
|
3 years
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Iradj Sobhani, MD, PhD, Assistance Publique - Hôpitaux de Paris
Publikationer och användbara länkar
Allmänna publikationer
- Sobhani I, Bergsten E, Charpy C, Chamaillard M, Mestivier D. Virulent Bacteria as Inflammatory and Immune Co-Factor in Colon Carcinogenesis: Evidence From Two Monozygotic Patients and Validation in CRC Patient and Healthy Cohorts. Front Cell Infect Microbiol. 2021 Nov 4;11:749750. doi: 10.3389/fcimb.2021.749750. eCollection 2021.
- Sobhani I, Bergsten E, Couffin S, Amiot A, Nebbad B, Barau C, de'Angelis N, Rabot S, Canoui-Poitrine F, Mestivier D, Pedron T, Khazaie K, Sansonetti PJ. Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures. Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24285-24295. doi: 10.1073/pnas.1912129116. Epub 2019 Nov 11.
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- AOM 09268
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Kolorektal cancer
-
Incyte CorporationMerck Sharp & Dohme LLCAvslutadMelanom | Lymfom | Huvud- och halscancer | Magcancer | Äggstockscancer | Hepatocellulärt karcinom (HCC) | Lungcancer | Blåscancer | Endometriecancer | Fasta tumörer | Njurcellscancer (RCC) | Trippel negativ bröstcancer (TNBC) | UC (Urotelial cancer) | Microsatellite-instability (MSI) High Colorectal Cancer (CRC)Förenta staterna
Kliniska prövningar på COLOHYBRITEST OR VALIHYBRITEST
-
Ornovi, Inc.Indragen
-
Devintec SaglMeditrial SrLRekryteringÅterkommande aftöst sårItalien
-
Laval UniversityOkändFrämre korsbandsskador | ACLKanada
-
Albany Medical CollegeAnmälan via inbjudan
-
Prim PD Dr Afshin AssadianWilhelminenspital ViennaOkändArteriella ocklusiva sjukdomar | Aortaaneurysm, bukenÖsterrike
-
Pacific Institute for Research and EvaluationKlein Buendel, Inc.AvslutadAggression | Drog användning | Peer Group | Drick för mycket | Fylle körning | Dricker, binge | Full | Aggression SexuellFörenta staterna
-
Sohag UniversityHar inte rekryterat ännu
-
Hartford HospitalUniversity of Maryland; University of ConnecticutAvslutadInflammatorisk respons | Bäckenorgan framfall | DysbiosFörenta staterna
-
University of Southern CaliforniaNorthwestern University; National Institute on Aging (NIA); AltaMed Health...AvslutadOpioidmissbruk, ospecificeratFörenta staterna
-
The Ojai FoundationAvslutad